Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
MB0151 in Locally Advanced Malignant Solid Neoplasm: NCT06840821 Clinical Landscape Report 2026
15 October 2026
NCT06840821 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Albumin-Bound Paclitaxel in Primary peritoneal carcinoma: NCT06840886 Clinical Landscape Report 2026
15 October 2026
NCT06840886 clinical landscape for Primary peritoneal carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[68]Ga-OncoCAlX in Renal Cell Carcinoma: NCT06840548 Clinical Landscape Report 2026](https://synapse-static-patsnap-com.libproxy1.nus.edu.sg/strapi-static/Blog_cover_14_36b6ffee12.jpg)
9 min read
[68]Ga-OncoCAlX in Renal Cell Carcinoma: NCT06840548 Clinical Landscape Report 2026
15 October 2026
NCT06840548 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Golcadomide Hydrochloride in Refractory High-Grade B-Cell Lymphoma: NCT06834373 Clinical Landscape Report 2026
15 October 2026
NCT06834373 clinical landscape for Refractory High-Grade B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Dinutuximab beta in Ewing Sarcoma: NCT06839703 Clinical Landscape Report 2026
15 October 2026
NCT06839703 clinical landscape for Ewing Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-CD19 CAR-T (The Children's Hospital of Philadelphia) in Lupus Nephritis: NCT06839976 Clinical Landscape Report 2026
15 October 2026
NCT06839976 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Doxorubicin Hydrochloride liposomal in Leiomyosarcoma: NCT06849986 Clinical Landscape Report 2026
15 October 2026
NCT06849986 clinical landscape for Leiomyosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fianlimab/Cemiplimab in Melanoma: NCT06848088 Clinical Landscape Report 2026
15 October 2026
NCT06848088 clinical landscape for Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RP903 in Ovarian Cancer: NCT06846099 Clinical Landscape Report 2026
15 October 2026
NCT06846099 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Primary mediastinal large B-cell lymphoma recurrent: NCT06838832 Clinical Landscape Report 2026
15 October 2026
NCT06838832 clinical landscape for Primary mediastinal large B-cell lymphoma recurrent: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
AWT-020 in Adenocarcinoma of large intestine: NCT06839105 Clinical Landscape Report 2026
15 October 2026
NCT06839105 clinical landscape for Adenocarcinoma of large intestine: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Albumin-Bound Paclitaxel in Cardiotoxicity: NCT06845319 Clinical Landscape Report 2026
15 October 2026
NCT06845319 clinical landscape for Cardiotoxicity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.